CHEK1 and colorectal cancer: We found that ATR inhibition abrogates BOLD-100 induced ATR/CHK1 activation, leading to synergistic decreases in cell viability and colony formation, in addition to robust increases in apoptosis when ATR inhibition was combined with BOLD-100 in BRAFMT colorectal cancer cells.